# Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea

> **NCT01983683** · PHASE3 · COMPLETED · sponsor: **Actelion** · enrollment: 631 (actual)

## Conditions studied

- Clostridium Difficile Infection

## Interventions

- **DRUG:** Cadazolid
- **DRUG:** Vancomycin
- **DRUG:** Cadazolid-matching placebo
- **DRUG:** Vancomycin-matching placebo

## Key facts

- **NCT ID:** NCT01983683
- **Lead sponsor:** Actelion
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12-12
- **Primary completion:** 2017-03-09
- **Final completion:** 2017-05-02
- **Target enrollment:** 631 (ACTUAL)
- **Last updated:** 2025-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01983683

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01983683, "Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01983683. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*